1-1 of 1
on behalf of the NN1250-3579 (BEGIN Once Long) Trial Investigators
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long)

Bernard Zinman, MD, Athena Philis-Tsimikas, MD, Bertrand Cariou, MD, Yehuda Handelsman, MD, Helena W. Rodbard, MD, Thue Johansen, MD, Lars Endahl, PHD, Chantal Mathieu, MD, on behalf of the NN1250-3579 (BEGIN Once Long) Trial Investigators
Journal: Diabetes Care
Diabetes Care 2012;35(12):2464–2471
https://doi.org/10.2337/dc12-1205
Published: 14 November 2012
View article titled, Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: <subtitle>A 1-year, randomized, treat-to-target trial (BEGIN Once Long)</subtitle>
Open the PDF for Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: <subtitle>A 1-year, randomized, treat-to-target trial (BEGIN Once Long)</subtitle> in another window
Includes: Supplementary data